IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | -68.7% | 7,335 | -73.9% | 0.00% | -75.0% |
| Q2 2020 | $771,000 | +15.8% | 28,101 | +26.3% | 0.00% | 0.0% |
| Q1 2020 | $666,000 | -3.5% | 22,246 | -10.8% | 0.00% | +33.3% |
| Q4 2019 | $690,000 | +52.0% | 24,941 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $454,000 | -61.7% | 24,941 | -48.4% | 0.00% | -66.7% |
| Q2 2019 | $1,185,000 | +100.8% | 48,330 | -22.1% | 0.01% | +100.0% |
| Q1 2019 | $590,000 | – | 62,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |